Condition: Adnexal Tumor of Skin · Merkel Cell Carcinoma · Advanced Basal Cell Carcinoma Requiring Systemic Treatment · Sponsor: University Hospital, Lille
Merkel cell carcinoma, advanced basal cell carcinoma requiring systemic treatment, and cutaneous adnexal carcinomas are 3 types of rare skin cancers for which much remains unknown in terms of natural behavior, prognosis, treatment and outcomes. CARADERM is a French prospective national cohort enrolling patients with either one of these 3 tumor types, whose objectives are : * to provide epidemiological, clinical and socio-economic characteristics of patients * to identify new clinical or epidemiological prognostic factors for these rare cancers * to evaluate the impact of various treatments on outcomes
This description comes directly from the study's public registry record.
Laurent MORTIER, MD,PhD · 03.20.44.41.93 · laurent.mortier@chru-lille.fr
Benoit Minart · benoit.minart@chru-lille.fr
Always discuss trial participation with your own doctor first.
| CHU Bocage | Dijon, Dijon, France | Recruiting |
| CH Le Mans | Le Mans, Le Mans, France | Recruiting |
| Centre hospitalier Lyon Sud | Pierre-Bénite, Pierre-benite, France | Recruiting |
| CHU Amiens Picardie | Amiens, France | Recruiting |
| CHU Angers | Angers, France | Recruiting |
| CH Annecy Gennevois | Annecy, France | Recruiting |
| CHU Besançon | Besançon, France | Recruiting |
| CHU Avicenne | Bobigny, France | Recruiting |
| CHU Ambroise Paré | Boulogne-Billancourt, France | Recruiting |
| CHU de Brest | Brest, France | Recruiting |
| CHU de Caen | Caen, France | Recruiting |
| CHU de Clermont Ferrand | Clermont-Ferrand, France | Recruiting |
+ 22 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03210935